Exact Mass: 254.0877644
Exact Mass Matches: 254.0877644
Found 353 metabolites which its exact mass value is equals to given mass value 254.0877644,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ketoprofen
Ketoprofen is only found in individuals that have used or taken this drug. It is a propionic acid derivative and is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties. The anti-inflammatory effects of ketoprofen are believed to be due to inhibition cylooxygenase-2 (COX-2), an enzyme involved in prostaglandin synthesis via the arachidonic acid pathway. This results in decreased levels of prostaglandins that mediate pain, fever and inflammation. Ketoprofen is a non-specific cyclooxygenase inhibitor and inhibition of COX-1 is thought to confer some of its side effects, such as GI upset and ulceration. Ketoprofen is thought to have anti-bradykinin activity, as well as lysosomal membrane-stabilizing action. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 205 CONFIDENCE standard compound; INTERNAL_ID 1150 CONFIDENCE standard compound; INTERNAL_ID 4086 CONFIDENCE standard compound; INTERNAL_ID 8562 D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
L-Phosphoarginine
L-Phosphoarginine is found in crustaceans. L-Phosphoarginine is a constituent of crayfish muscle KEIO_ID P105
Chalepensin
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D011564 - Furocoumarins
2-Hydroxyfelbamate
C11H14N2O5 (254.09026740000002)
2-Hydroxyfelbamate is a metabolite of felbamate. Felbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy. (Wikipedia)
p-Hydroxyfelbamate
C11H14N2O5 (254.09026740000002)
p-Hydroxyfelbamate is a metabolite of felbamate. Felbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy. (Wikipedia)
1-(2-hydroxy-4-methoxyphenyl)-3-phenylprop-2-en-1-one
3-(2-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
L-Agaridoxin
C11H14N2O5 (254.09026740000002)
L-Agaridoxin is found in mushrooms. L-Agaridoxin is a constituent of Agaricus campestris (field mushroom)
3,6-Dimethoxy-4-phenanthrenol
3,6-Dimethoxy-4-phenanthrenol is found in opium poppy. 3,6-Dimethoxy-4-phenanthrenol is found in opiu
2,6-Dimethoxy-4-phenanthrenol
2,6-Dimethoxy-4-phenanthrenol is found in poppy seeds, opium poppy and opium extracts. Found in opium extracts
Dexketoprofen
Dexketoprofen belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in the production of chemicals in the body called prostaglandins. Prostaglandins are produced in response to injury or certain diseases and would otherwise go on to cause swelling, inflammation and pain. By blocking cyclo-oxygenase, dexketoprofen prevents the production of prostaglandins and therefore reduces inflammation and pain. Along with Peripheral analgesic action it possesses central analgesic action. Dexketoprofen is a non-steroidal anti-inflammatory drug. It is manufactured by Menarini, under the tradename Keral. It is available in the UK, as dexketoprofen trometamol, as a prescription-only drug and in Latin America as Miracox, produced by Stein in Costa Rica. In Italy it is available as an over the counter-drug under the tradename Enantyum. In Lithuania it is available as over the counter-drug uder tradename Dolmen. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Butanoic acid, [(diethoxyphosphinyl)oxy]methyl ester
Fenbufen
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Indolocarbazole
fenbufen
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
2-{[1-Cyano-2-(dimethylamino)vinyl]sulfonyl}-3-(dimethylamino)acrylonitrile
5-Methoxyflavanone
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.122 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.121
4-methoxy-3-methylnaphto[1,2-b]oxepin-2(3H)-one|aggregatin B
(3R,4R)-3,4-dihydro-4,8-dihydroxy-6,7-dimethoxy-3-methylisocoumarin|3,4-Dihydro-4,8-dihydroxy-6,7-dimethoxy-3-methyl-1H-2-benzopyran-1-one
4-Acetoxy-3,5-dimethoxy-benzoesaeure-methylester|4-acetoxy-3,5-dimethoxy-benzoic acid methyl ester|Acetylsyringasaeure-methylester|AMS|methyl 4-acetoxy-3,5-dimethoxybenzoate|methyl 4-acetyl syringate
Me ether-2,3-Dihydro-3-hydroxy-2-phenyl-4H-1-benzopyran-4-one
9-methyl-6a,11a-dihydro-6H-benzofuro[3,2-c]chromen-3-ol
4-[4-hydroxy-3-methoxyphenyl]-indan-1-one|afzeliindanone
3-O-Methylcyclopolsaeure|3-O-Metyl-cyclopolsaeure|Me ether-Cyclopolic acid
methyl (2Z,4E)-6(acetyloxy)-5-formyl-7-oxoocta-2,4-dienoate
4-(2,3-dihydroxy-5-methoxy-4-methylphenyl)-4-oxobutanoic acid
2,7-dihydroxy-1-methyl-5-aldehyde-9,10-dihydrophenanthrene|2,7-dihydroxy-1-methyl-9,10-dihydrophenanthrene-5-carbaldehyde
3-Ethoxycarbonyl-2-hydroxy-6-methoxy-4-methylbenzoic acid
3-Hydroxy-5-methoxy-benzalacetophenon|3-hydroxy-5-methoxybenzalacetophenone
(3R*,4S*)-3,4-dihydro-3,4,8-trihydroxy-3-(hydroxymethyl)-6-methoxynaphthalen-1(2H)-one|balticol C
1,12-diacetoxy-7-phenylhept-2c-ene-4,6-diyne|3-Me ether,1-Ac-(Z)-7-(3-Hydroxyphenyl)-2-phenyl-4,6-diyn-1-ol
5-hydroxymethyl-2-(4-hydroxyphenyl)-3-methylbenzofuran
(5S,7S)-7-acetoxy-5,10-dihyroxy-Delta8,9dolichodial|jatamanin M
ketoprofen
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors relative retention time with respect to 9-anthracene Carboxylic Acid is 1.070 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.068 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.071
6-(2-methylbut-3-en-2-yl)furo[3,2-g]chromen-7-one
6-methoxy-2-phenyl-2,3-dihydrochromen-4-one
2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one
(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid
L-Agaridoxin
C11H14N2O5 (254.09026740000002)
Dexketoprofen
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2-(3-(METHYLAMINO)PROPYL)ISOINDOLINE-1,3-DIONE HYDROCHLORIDE
3-methyl-N-(4-methylphenyl)-1,3-benzothiazol-2-imine
2-Propen-1-one,1-(2-hydroxyphenyl)-3-(3-methoxyphenyl)-
Phenol,2-(1-methylbutyl)-4,6-dinitro-
C11H14N2O5 (254.09026740000002)
3-(PIPERIDIN-4-YL)BENZO[D]OXAZOL-2(3H)-ONE HYDROCHLORIDE
Dimethyl 2,5-dioxobicyclo[2.2.2]octane-1,4-dicarboxylate
4-chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
1h-indol-3-ylmethylamine oxalate hemihydrate
C11H14N2O5 (254.09026740000002)
2-DEOXY-2,2-DIFLUORO-4,5-O-(1-METHYLETHYLIDENE)-L-ERYTHRO-PENTONIC ACID, ETHYL ESTER
C10H16F2O5 (254.09657499999997)
(6-CHLOROPYRIDAZIN-3-YL)(4-ETHYLPIPERAZIN-1-YL)METHANONE
C11H15ClN4O (254.09343299999998)
3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
2-(1,3-benzodioxol-5-yl)imidazo[1,2-a]pyrimidin-3-amine
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylic acid
2,4-DIHYDRO-5-(4-FLUOROPHENYL)-2-PHENYL-3H-PYRAZOL-3-ONE
(7R)-2-Chloro-7-ethyl-7,8-dihydro-8-(1-methylethyl)-6(5H)-pteridinone
C11H15ClN4O (254.09343299999998)
3-Chloro-4-hydroxyphenylboronic acid, pinacol ester
ethyl 2-methyl-2-(2-methyl-4-sulfanyl-phenoxy)propanoate
Methyl 3-methoxy-2-(2-methoxy-2-oxoethoxy)benzoate
4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
ETHYL (2E)-3-[4-[AMINO(IMINO)METHYL]PHENYL]ACRYLATE HYDROCHLORIDE
3,4-dihydro-2h-1,5-benzodioxepin-7-yl(phenyl)methanone
2-Chloro-1-(3-Methyl-2,3,5,6-tetrahydro-[1,2]bipyrazinyl-4-yl)-ethanone
C11H15ClN4O (254.09343299999998)
Purine-9-beta-D-(2-deoxy-2-fluoro) arabinoriboside
2-Propen-1-one,3-(4-hydroxyphenyl)-1-(4-methoxyphenyl)-
2-CHLORO-3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOL
2,8-Diazaspiro[4.5]decane, 8-(methylsulfonyl)-, hydrochloride (1:1)
5-(TERT-BUTYL)-2-METHOXY-1,3-DINITROBENZENE
C11H14N2O5 (254.09026740000002)
Ethyl (3R,S)-2,2-difluoro-3-hydroxy-3-(2,2-dimethyldioxolan-4-yl)propionate
C10H16F2O5 (254.09657499999997)
3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
2-HYDROXY-5-IMIDAZO[1,2-A]PYRIMIDIN-2-YL-BENZAMIDE
1-(2-Hydroxy-5-methylphenyl)-3-phenylpropane-1,3-dione
2-fluoro-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]acetic acid
C13H15FO4 (254.09543219999998)
Phenol,4-(1,1-dimethylpropyl)-2,6-dinitro-
C11H14N2O5 (254.09026740000002)
N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide
C11H14N2O5 (254.09026740000002)
(2S)-5-amino-2-(3,4-dihydroxyanilino)-5-oxopentanoic acid
C11H14N2O5 (254.09026740000002)
N-(3-hydroxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
Trimethylsilyl 3,4-dimethoxybenzoate
C12H18O4Si (254.09743079999998)
Methyl 3-methoxy-4-[(trimethylsilyl)oxy]benzoate
C12H18O4Si (254.09743079999998)
Methyl 4-methoxy-3-trimethylsilyloxybenzoate
C12H18O4Si (254.09743079999998)
5,6-Dimethyl-3-[5-(trifluoromethyl)pyridin-2-yl]-1,2,4-triazine
3-(4,7-Dimethoxy-1,3-benzodioxol-5-yl)propanoic acid
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)propanoic acid
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-2-hydroxypropanal
[3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)oxiran-2-yl]methanol
3-(6-Hydroxy-2,3,4-trimethoxyphenyl)prop-2-enoic acid
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-3-hydroxypropanal
3,5-Dimethoxy-4-[(trimethylsilyl)oxy]benzaldehyde
C12H18O4Si (254.09743079999998)
Methyl 4-methoxysalicylate, TMS derivative
C12H18O4Si (254.09743079999998)
2,5-Dimethoxybenzoic acid, trimethylsilyl ester
C12H18O4Si (254.09743079999998)
2-Amino-5-[[amino-(phosphonoamino)methylidene]amino]pentanoic acid
(R)-4-methoxydalbergione
A member of the class of 1,4-benzoquinones that is p-benzoquinone substituted by a methoxy group at position 2 and a 1-phenylallyl group at position 5. Isolated from the heartwood of Dalbergia louveli, it exhibits antiplasmodial activity.
N(Omega)-phospho-L-arginine
An arginine derivative that is L-arginine substituted by a phosphono group at N(omega)-position.
2,3-dihydroxypropyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
2-(4-hydroxy-5-methoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)ethyl acetate
2-methoxy-5-[(1s)-1-phenylprop-2-en-1-yl]cyclohexa-2,5-diene-1,4-dione
9-methoxy-3,8-dimethylnaphtho[2,3-b]furan-4-carbaldehyde
3-hydroxy-4-(4-hydroxy-3,5-dimethoxyphenyl)oxolan-2-one
(3r,4s)-4-hydroxyoxolan-3-yl 2,4-dihydroxy-6-methylbenzoate
(2s)-2-amino-4-[(3,4-dihydroxyphenyl)-c-hydroxycarbonimidoyl]butanoic acid
C11H14N2O5 (254.09026740000002)
3-hydroxy-5,7-dimethoxy-2-methyl-2,3-dihydro-1-benzofuran-6-carboxylic acid
4,6,8-trihydroxy-3-methoxy-3,7-dimethyl-4h-2-benzopyran-1-one
14-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaen-5-ol
methyl (2z,4e,6s)-6-(acetyloxy)-5-formyl-7-oxoocta-2,4-dienoate
3-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1(10),2,4,6,14-pentaen-9-one
1-o-caffeoylglycerol
{"Ingredient_id": "HBIN002861","Ingredient_name": "1-o-caffeoylglycerol","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OCC(CO)O)O)O","Ingredient_weight": "254.24 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2907","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5315606","DrugBank_id": "NA"}
1-o-caffoylglycerol
{"Ingredient_id": "HBIN002863","Ingredient_name": "1-o-caffoylglycerol","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OCC(CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30716","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-o-coumaroylglycerol; (s,e)-form,3'-hydroxy
{"Ingredient_id": "HBIN002869","Ingredient_name": "1-o-coumaroylglycerol; (s,e)-form,3'-hydroxy","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "NA","Ingredient_weight": "254.24","OB_score": "NA","CAS_id": "138812-55-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9139","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-3,7-dimethoxyphenanthrene
{"Ingredient_id": "HBIN005740","Ingredient_name": "2-hydroxy-3,7-dimethoxyphenanthrene","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "COC1=CC2=C(C=C1)C3=CC(=C(C=C3C=C2)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10033","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-oxobicyclo(3. 2. 2)nona- 3,6- dien- 1- yl benzoate
{"Ingredient_id": "HBIN006279","Ingredient_name": "2-oxobicyclo(3. 2. 2)nona- 3,6- dien- 1- yl benzoate","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "C1CC2C=CC1C=C(C2=O)OC(=O)C3=CC=CC=C3","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41568","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(7S,8R)-dihydrodehydrodiconiferylalcohol-4-O-(β-D-glucopyranoside
{"Ingredient_id": "HBIN013475","Ingredient_name": "(7S,8R)-dihydrodehydrodiconiferylalcohol-4-O-(\u03b2-D-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "CC1C(OC2=C1C=C(C=C2)C=O)C3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41995","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(7S,8R)-dlihydrodehydrodiconiferyl alcohol-9-o-bei-D-glucoside
{"Ingredient_id": "HBIN013476","Ingredient_name": "(7S,8R)-dlihydrodehydrodiconiferyl alcohol-9-o-bei-D-glucoside","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "CC1C(OC2=C1C=C(C=C2)C=O)C3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42857","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s,3r)-2-{[(3-amino-2-hydroxyphenyl)(hydroxy)methylidene]amino}-3-hydroxybutanoic acid
C11H14N2O5 (254.09026740000002)
2',5-dihydroxy-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2-carbaldehyde
4',6-dihydroxy-3'-(prop-2-en-1-yl)-[1,1'-biphenyl]-3-carbaldehyde
4-(3-carboxy-2-hydroxy-3-methylpropoxy)benzoic acid
(4e)-2-hydroxy-5-methoxy-4-[(2e)-3-phenylprop-2-en-1-ylidene]cyclohexa-2,5-dien-1-one
6-[(1r)-2,2-dimethylcyclopropyl]furo[3,2-g]chromen-7-one
3-(4-hydroxy-2-methoxyphenyl)-1-phenylprop-2-en-1-one
(1r,9s,16s)-9-methyl-15-oxatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-2(7),4,10,12-tetraene-3,6-dione
(2e)-3-(4-hydroxy-2-methoxyphenyl)-1-phenylprop-2-en-1-one
(1r,15s)-15-methyl-8,14-dioxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6,9,11,13(17)-hexaen-3-ol
4,6,8-trihydroxy-3-(hydroxymethyl)-4,5-dimethyl-3h-2-benzopyran-1-one
5-(5-acetyl-4-hydroxy-6-oxopyran-2-yl)pentanoic acid
3-hydroxy-2-(1,2,3-trihydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carbaldehyde
(2r,3s)-3-hydroxy-5,7-dimethoxy-2-methyl-2,3-dihydro-1-benzofuran-6-carboxylic acid
(2z)-7-(3-methoxyphenyl)hept-2-en-4,6-diyn-1-yl acetate
2-(1-methoxy-3-phenylprop-2-en-1-ylidene)-4-methylcyclopent-4-ene-1,3-dione
6-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-13-ol
5-[(1e)-2-(3-methoxyphenyl)ethenyl]-2h-1,3-benzodioxole
5-[2-(4-methoxyphenyl)ethenyl]-2h-1,3-benzodioxole
13-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-6-ol
3-(11-hydroxyundec-2-en-5,7,9-triyn-1-yl)-5-methyl-5h-furan-2-one
2-methoxy-5-(1-phenylprop-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione
1-(4-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
4-[(2r,3r)-3-carboxy-2-hydroxy-3-methylpropoxy]benzoic acid
(1r,10r)-14-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaen-5-ol
(2e)-2-[(2e)-1-methoxy-3-phenylprop-2-en-1-ylidene]-4-methylcyclopent-4-ene-1,3-dione
(4z)-2-hydroxy-5-methoxy-4-[(2e)-3-phenylprop-2-en-1-ylidene]cyclohexa-2,5-dien-1-one
(2e)-2-benzyl-3-(4-hydroxyphenyl)prop-2-enoic acid
4-(4-hydroxy-3-methoxyphenyl)-2,3-dihydroinden-1-one
methyl 3-(2,4-dihydroxy-6-methylbenzoyloxy)propanoate
(3s,4r)-4,6,8-trihydroxy-3-(hydroxymethyl)-4,5-dimethyl-3h-2-benzopyran-1-one
(1s,2s,4r,8r,9r)-8-hydroxy-4,10,10-trimethyl-3,11,12,13-tetraoxatetracyclo[7.3.1.0¹,⁷.0²,⁴]tridec-6-en-5-one
3,4-dihydroxy-2-methyl-7-(3-methyloxiran-2-yl)-2h,3h,4h-pyrano[4,3-b]pyran-5-one
8-hydroxy-4,10,10-trimethyl-3,11,12,13-tetraoxatetracyclo[7.3.1.0¹,⁷.0²,⁴]tridec-6-en-5-one
(3r)-5-hydroxy-4-(hydroxymethyl)-3,7-dimethoxy-6-methyl-3h-2-benzofuran-1-one
14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaene
(2s,3s,4s)-3,4-dihydroxy-2-methyl-7-[(2r,3r)-3-methyloxiran-2-yl]-2h,3h,4h-pyrano[4,3-b]pyran-5-one
(2s,3r)-2-(4-hydroxyphenyl)-3-methyl-2,3-dihydro-1-benzofuran-5-carbaldehyde
(2s,3s)-3-hydroxy-2-(1,2,3-trihydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carbaldehyde
(2r,3r)-2-(4-hydroxyphenyl)-3-methyl-2,3-dihydro-1-benzofuran-5-carbaldehyde
(2s)-2-[(3,4-dihydroxyphenyl)amino]-4-(c-hydroxycarbonimidoyl)butanoic acid
C11H14N2O5 (254.09026740000002)
(2e)-1-(2-hydroxy-4-methoxyphenyl)-3-phenylprop-2-en-1-one
(2e)-1-(4-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
3-hydroxy-4-[4-(prop-2-en-1-yl)phenoxy]benzaldehyde
(12s,16r)-3-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1(10),2,4,6,14-pentaen-9-one
2-(4-hydroxyphenyl)-3-methyl-2,3-dihydro-1-benzofuran-5-carbaldehyde
(1s,10s)-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaene
5-hydroxy-4-(hydroxymethyl)-3,7-dimethoxy-6-methyl-3h-2-benzofuran-1-one
(5r)-3-[(2z)-11-hydroxyundec-2-en-5,7,9-triyn-1-yl]-5-methyl-5h-furan-2-one
(2s)-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
2-amino-4-[(3,4-dihydroxyphenyl)-c-hydroxycarbonimidoyl]butanoic acid
C11H14N2O5 (254.09026740000002)